Hermès Sales Climb, Boosted By US
Hermès second quarter sales rose 7 percent, lifted by a recovery in tourism in Europe and strong demand in the US.

Paloma Elsesser joined The Business of Beauty’s executive editor Priya Rao about staying true to herself amid the pressures of tokenism and why — after a decade building other people’s brands — she’s finally thinking about building one of her own.

Paloma Elsesser joined The Business of Beauty’s executive editor Priya Rao about staying true to herself amid the pressures of tokenism and why — after a decade building other people’s brands — she’s finally thinking about building one of her own.

Galderma's shares slumped the most in more than a year after US regulators turned down the Swiss dermatology firm’s rival Botox treatment Relfydess.

Galderma's shares slumped the most in more than a year after US regulators turned down the Swiss dermatology firm’s rival Botox treatment Relfydess.

The model and muse explained her supermodel origin story and her plans for her next act onstage at The Business of Beauty Global Forum.

The model and muse explained her supermodel origin story and her plans for her next act onstage at The Business of Beauty Global Forum.

Once overlooked, pregnancy and perinatal care is becoming an increasingly innovative category. Emerging founders are building global beauty brands rooted in safety, science and emotional connection, proving that “mama care” can be both elevated and enduring.

Once overlooked, pregnancy and perinatal care is becoming an increasingly innovative category. Emerging founders are building global beauty brands rooted in safety, science and emotional connection, proving that “mama care” can be both elevated and enduring.
ADVERTISEMENT

The Ozempic maker has inked a deal with the discount retailer as GLP-1 drug prices have soared.

The Ozempic maker has inked a deal with the discount retailer as GLP-1 drug prices have soared.

The pharmaceutical boom in weight-loss drugs has put companies like Novo Nordisk and Eli Lilly in ever-fiercer competition. Now more heavyweights, like Pfizer and Astrazeneca, are entering the ring. Who will come out on top?

The pharmaceutical boom in weight-loss drugs has put companies like Novo Nordisk and Eli Lilly in ever-fiercer competition. Now more heavyweights, like Pfizer and Astrazeneca, are entering the ring. Who will come out on top?

Shares of pot companies rose on Monday after US president Donald Trump advocated the potential benefits from the use of cannabidiol in senior healthcare in a social media post.

Shares of pot companies rose on Monday after US president Donald Trump advocated the potential benefits from the use of cannabidiol in senior healthcare in a social media post.

The Canadian retailer is collaborating with body care label Salt & Stone to launch an exclusive collection — and apply its accessible, quiet luxury proposition to a whole new category.

The Canadian retailer is collaborating with body care label Salt & Stone to launch an exclusive collection — and apply its accessible, quiet luxury proposition to a whole new category.
ADVERTISEMENT

Marketing to players has become big business as the athletes themselves become bigger tastemakers, prompting salons and brands to offer their services to the cream of the crop.

Marketing to players has become big business as the athletes themselves become bigger tastemakers, prompting salons and brands to offer their services to the cream of the crop.

Gen-Z beauty consumers of colour are embracing self-tanning products. Their goals might not be to darken their skin, but to enhance radiance and glow, and even flip the script on colourism. To capture this new market, brands must play catch-up.

Gen-Z beauty consumers of colour are embracing self-tanning products. Their goals might not be to darken their skin, but to enhance radiance and glow, and even flip the script on colourism. To capture this new market, brands must play catch-up.

We solved the problem of getting men into wellness. Now we have the bigger problem of what we’ve turned them into, writes meditation teacher Manoj Dias.

We solved the problem of getting men into wellness. Now we have the bigger problem of what we’ve turned them into, writes meditation teacher Manoj Dias.

The Estée Lauder Companies, which is behind global beauty brands including Bobbi Brown Cosmetics, Clinique, Jo Malone London, La Mer and Tom Ford Beauty, has new leadership driving strategic change and innovation in the workplace. BoF speaks to Pernilla Nyberg, SVP and general manager of UK & Ireland, to learn how the company is engaging and supporting its employees amid the change.

The Estée Lauder Companies, which is behind global beauty brands including Bobbi Brown Cosmetics, Clinique, Jo Malone London, La Mer and Tom Ford Beauty, has new leadership driving strategic change and innovation in the workplace. BoF speaks to Pernilla Nyberg, SVP and general manager of UK & Ireland, to learn how the company is engaging and supporting its employees amid the change.
Hermès second quarter sales rose 7 percent, lifted by a recovery in tourism in Europe and strong demand in the US.
According to documents the ultra-fast-fashion company filed in connection with its planned Hong Kong IPO, Shein is cooperating with the investigation and could face significant fines.
The billionaire Mike Ashley’s investment arm disclosed Tuesday it holds an interest worth a potential 4.2 percent of the voting rights in Burberry.
The Franco-Italian eyewear maker reported a 15 percent rise in first-half profit, beating expectations, while revenue growth was driven by strong demand for AI-enabled glasses myopia products.
Leahy joins the wearables brand from Glossier, where she was chief executive for three years.
The jeweller lost $2.1 billion in market value after forecasting first-half 2026 revenue growth of up to 66 percent, a sharp slowdown from last year that unsettled investors in one of China’s most viral consumer brands.
Unilever upgraded its annual forecast on Tuesday, as consumers reached for brands like Vaseline and Dove despite household budget concerns stemming from the Iran war.
Johnson & Johnson on Monday said it agreed to a $5.5 billion commitment to resolve years of litigation related to claims that its talc products caused ovarian cancer.